Can post-rt neck dissection be omitted for patients with head-and-neck cancer who have a negative pet scan after definitive radiation therapy?

International Journal of Radiation Oncology Biology Physics

Volumn 58, Issue 3, 2004, Pages 694-697

  Rogers, John W ^a   Greven, Kathryn M ^a   McGuirt, W Frederick ^a   Keyes Jr , John W ^a   Williams III, Dan W ^a   Watson, Nat E ^a   Geisinger, Kim ^a   Cappellari, James O ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Head and neck cancer; Neck dissection; Positron emission tomography

Indexed keywords

DISEASES; MAGNETIC RESONANCE IMAGING; PATIENT TREATMENT; POSITRON EMISSION TOMOGRAPHY; RADIOTHERAPY; TUMORS;

NECK DISSECTION; POSTTREATMENT SCANS;

ONCOLOGY;

FLUORODEOXYGLUCOSE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; HEAD AND NECK CANCER; HUMAN; INTERMETHOD COMPARISON; MINIMAL RESIDUAL DISEASE; NECK DISSECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 1242338156     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)01625-0     Document Type: Article

References (15)

1. Mendenhall W.M., Villaret D.B., Amdur R.J., et al. Planned neck dissection after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck. 24:2002;1012-1018.
2. Peters L.J., Weber R.S., Morrison W.H., et al. Neck surgery in patients with primary oropharyngeal cancer treated by radiotherapy. Head Neck. 18:1996;552-559.
3. Greven K.M., Williams D.W. III, Keyes J.W. Jr, et al. Positron emission tomography of patient with head and neck carcinoma before and after high dose irradiation. Cancer. 74:1994;1355-1359.
4. Lowe V.J., Kim H., Boyd J.H., Eisenbeis J.F., et al. Primary and recurrent early stage laryngeal cancer preliminary results of 2- . [fluorine-18]-fluoro-2-deoxy-D-glucose PET imaging Radiology. 212:1999;799-802.
5. Wong W.L., Chevretton E.B., McGurk M., et al. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma. Clin Otolaryngol. 22:1997;209-214.
6. Paulus P., Sambon A., Vifegnis D., et al. 18FDG-PET for the assessment of primary head and neck tumors Clinical, computed tomography, and histopathological correlation in 38 patients . Laryngoscope. 358:1998;254-260.
7. Hannah A., Scott A.M., Tochon-Danguy H., et al. Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer. Ann Surg. 236:2002;208-217.
8. Brink I., Klezner T., Krause T., et al. Lymph node staging in extracranial head and neck cancer with FDG-PET - appropriate uptake period and size dependence of the results. Nuklearmedizin. 41:2002;108-113.
9. Stuckenson T., Kovacs A.F., Adams S., et al. Staging of the neck in patients with oral cavity squamous cell carcinomas a prospective comparison of PET, ultrasound, CT and MRI . J Craniomaxillofac Surg. 28:2000;319-324.
10. McGuirt W.F., Williams D.W. III, Keyes J.W. Jr, et al. A comparative diagnostic study of head and neck nodal metastases using positron emission tomography. Laryngoscope. 105:1995;373-375.
11. Greven K.M., Williams D.W. III, McGuirt W.F., et al. Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck. 23:2001;942-946.
12. Brun E., Kjellen E., Tennvall J., et al. FDG-PET studies during treatment Prediction of therapy outcome in head and neck squamous cell carcinoma . Head Neck. 24:2002;127-135.
13. Sakamoto H., Nakai Y., Ohashi Y., et al. Monitoring of response to radiotherapy with fluorine-18 deoxyglucose PET of head and neck squamous cell carcinomas. Acta Otolaryngol Suppl. 538:1998;254-260.
14. Lowe V.J., Boyd J.H., Dunphy F.R., et al. Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol. 18:2000;651-658.
15. Lapela M., Egitved A., Jyrikkio S., et al. Experience in qualitative and quantitative FDG-PET in follow up of patients with suspected recurrence from head and neck cancer. Eur J Cancer. 36:2000;858-867.